Elsevier

Biochemical Pharmacology

Volume 52, Issue 10, 22 November 1996, Pages 1545-1552
Biochemical Pharmacology

Research paper
Modulation of the function of human MDR1 P-glycoprotein by the antimalarial drug mefloquine

https://doi.org/10.1016/S0006-2952(96)00556-4Get rights and content

Abstract

MDR1 P-glycoprotein in membranes of human tumor cells of the CEM/VBL100 line was selectively labelled using photoreactive analogs of verapamil, N-(p-azido-3-[125I]salicyl)amino-verapamil ([125I]ASA-V) and prazosin, 2-[4-(4-azido-3-[125I]iodobenzoyl)piperazin-1-yl]4-amino-6,7-dimethoxyyquinazoline ([125I]ASA-P). Mefloquine, a quinolinemethanol antimalarial drug, was shown to inhibit the labelling of P-glycoprotein with an efficiency similar to that for verapamil, a known chemosensitizer. By contrast, chloroquine competed poorly for the binding site on P-glycoprotein. Mefloquine also inhibited the functional activity of P-glycoprotein. It decreased the rates of extrusion of [3H]vinblastine and the fluorescent dyes, fluo-3 acetomethoxy ester and rhodamine 123, from drug-resistant cells and decreased the level of resistance of these cells to vinblastine. The ability of mefloquine to inhibit P-glycoprotein function may be involved in the neurotoxic side-effects occasionally associated with the use of mefloquine as an antimalarial drug.

References (43)

  • Q Wang et al.

    Effect of the P-glycoprotein inhibitor, cyclosporin A, on the distribution of rhodamine-123 to the brain: An in vivo microdialysis study in freely moving rats

    Biochem Biophys Res Commun

    (1995)
  • C Luxemburger et al.

    Mefloquine for multidrugresistant malaria

    Lancet

    (1991)
  • MM Gottesman et al.

    Biochemistry of multidrug resistance mediated by the multidrug transporter

    Annu Rev Biochem

    (1993)
  • JR Riordan et al.

    Amplification of P-glycoprotein genes in multidrugresistant mammalian cell lines

    Nature

    (1985)
  • JM Ford et al.

    Pharmacology of drugs that alter multidrug resistance in cancer

    Pharmacol Rev

    (1990)
  • AR Safa

    Photoaffinity labelling of the multidrug-resistancerelated P-glycoprotein with photoactive analogs of verapamil

  • R Boer et al.

    Reversible labeling of a chemosensitizer binding domain of P-glycoprotein with a novel 1,4-dihydropyridine drug transport inhibitor

    Biochemistry

    (1996)
  • BI Sikic

    Modulation of multidrug resistance: At the threshold

    J Clin Oncol

    (1993)
  • BL Lum et al.

    Clinical trials of modulation of multidrug resistance

    Cancer

    (1993)
  • S-I Akiyama et al.

    Most drugs that reverse multidrug resistance also inhibit photoaffinity labelling of P-glycoprotein by a vinblastine analog

    Mol Pharmocol

    (1988)
  • E Solary et al.

    Sufficient levels of quinine in serum circumvent the multidrug resistance of the leukemic cell line K562/ADM

    Cancer

    (1991)
  • Cited by (0)

    This work was supported by the National Health and Medical Research Council, Australia.

    View full text